GSO ISO 80601-2-85:2023

ISO 80601-2-85:2021
Gulf Standard   Current Edition · Approved on 03 May 2023

Medical electrical equipment — Part 2-85: Particular requirements for the basic safety and essential performance of cerebral tissue oximeter equipment

GSO ISO 80601-2-85:2023 Files

English 107 Pages
Current Edition Reference Language
90.09 BHD

GSO ISO 80601-2-85:2023 Scope

This document applies to basic safety and essential performance of cerebral tissue oximeter equipment, that employs light at multiple wavelengths to derive a quantitative measure of oxygen saturation of haemoglobin within the volume of tissue sampled under the probe attached to the head. The cerebral tissue oximeter equipment can be based on continuous light, frequency domain or time domain technologies. This document applies to ME equipment used in a hospital environment as well as when used outside the hospital environment, such as in ambulances and air transport. Additional standards may apply to ME equipment for those environments of use.

NOTE 1 Cerebral tissue oximeters are sometimes referred to as near infrared spectroscopy equipment in medical literature.

Not included within the scope of this document are:

  • invasive tissue or vascular oximeters;
  • oximeters that require a blood sample from the patient;
  • equipment measuring dissolved oxygen;
  • ME equipment, or part thereof, that measures path-length-dependent haemoglobin change. The requirements for functional near-infrared spectroscopy equipment are found in ISO 80601-2-71[4];
  • ME equipment, or part thereof, that measures arterial saturation based on pulsatile changes in tissue optical properties (SpO2). The requirements for pulse oximeter equipment are found in ISO 80601‑2‑61[3];
  • ME equipment, or any part thereof, that claims to monitor tissue in parts of the body other than the head.

This document also applies to cerebral tissue oximeter equipment, including cerebral tissue oximeter monitors, cerebral tissue oximeter probes and probe cable extenders, that have been remanufactured.

If a clause or subclause is specifically intended to be applicable to ME equipment only, or to ME systems only, the title and content of that clause or subclause will say so. If that is not the case, the clause or subclause applies both to ME equipment and to ME systems, as relevant.

Hazards inherent in the intended physiological function of ME equipment or ME systems within the scope of this document are not covered by specific requirements in this document except in 201.11 and in 201.7.2.13 and 201.8.4.1 of the general standard.

NOTE 2 See also 4.2 of the general standard.

This document can also be applied to ME equipment and their accessories used for compensation or alleviation of disease, injury or disability.

This document is not applicable to remote or slave (secondary) equipment that displays StO2 values that are located outside of the patient environment.

NOTE 3 ME equipment that provides selection between diagnostic and monitoring functions is expected to meet the requirements of the appropriate document when configured for that function.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
BH GSO 2017:2023
GSO 2017:2023 
Bahraini Standard
Personal Care and Baby Wet Wipes
BH GSO 2241:2023
GSO 2241:2023 
Bahraini Standard
Cosmetic Products - Body Cleaners
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners

Recently Published from Health Sector

GSO ISO 11608-7:2024
ISO 11608-7:2016 
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 7: Accessibility for persons with visual impairment
GSO ISO/TR 24666:2024
ISO/TR 24666:2023 
Gulf Standard
Sports and recreational facilities — Probes for entrapment/entanglement on playground equipment — Collection of data
GSO ISO 9713:2024
ISO 9713:2022 
Gulf Standard
Neurosurgical implants — Self-closing intracranial aneurysm clips
GSO ISO/TS 22690:2024
ISO/TS 22690:2021 
Gulf Standard
Genomics informatics — Reliability assessment criteria for high-throughput gene-expression data